Minimal residual disease response with venetoclax monotherapy in relapsed/refractory CLL patients: VENICE I, phase 3b exploratory analysis

Date

2020

Author

Kater, Arnon
Panagiotis, Panayiotidis
Aktan, Melih
Arslan, Onder
Demirkan, Fatih
Enggaard, Lisbeth
Forconi, Francesco

Metadata

Show full item record

Abstract

…

Source

Leukemia & Lymphoma

Volume

61

URI

https://hdl.handle.net/20.500.12712/10129

Collections